FUSIONTX Trademark

Trademark Overview

On Monday, April 13, 2026, a trademark application was filed for FUSIONTX with the United States Patent and Trademark Office. The USPTO has given the FUSIONTX trademark a serial number of 99760516. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 13, 2026. This trademark is owned by HighTide Therapeutics USA LLC. The FUSIONTX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Scientific research for medical purposes in the area of cancerous diseases; Research on the subject of pharmaceuticals; Research and development in the field of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Scientific research for medical purposes in the field of diseases of the digestive system
fusiontx

General Information

Serial Number99760516
Word MarkFUSIONTX
Filing DateMonday, April 13, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, April 13, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkFUSION TRANSACTION
Goods and ServicesPharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Pseudo MarkFUSION TRANSMISSION
Pseudo MarkFUSION TEXAS
Pseudo MarkFUSION TX
Pseudo MarkFUSION TREATMENT
Goods and ServicesScientific research for medical purposes in the area of cancerous diseases; Research on the subject of pharmaceuticals; Research and development in the field of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Scientific research for medical purposes in the field of diseases of the digestive system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 13, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 13, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHighTide Therapeutics USA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20852
US

Trademark Events

Event DateEvent Description
Monday, April 13, 2026NEW APPLICATION ENTERED
Monday, April 13, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

fusiontx diseases research system medical pharmaceutical purposes neurological gastrointestinal respiratory ophthalmic